
Leo Pharma’s lawsuit against Indian generic drugmaker Glenmark has concluded in a settlement, Leo Pharma informs MedWatch by email.
”The lawsuit resolved in a confidential settlement in April. Leo Pharma is pleased that the patent infringement case against Glenmark has been settled,” writes Leo Pharma’s patent department in the US.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app